Ameritas Investment Partners’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-2,444
| Closed | -$24.4K | – | 3178 |
|
|
2025
Q2 | $24.4K | Hold |
2,444
| – | – | ﹤0.01% | 2571 |
|
|
2025
Q1 | $14.6K | Hold |
2,444
| – | – | ﹤0.01% | 2679 |
|
|
2024
Q4 | $18.8K | Hold |
2,444
| – | – | ﹤0.01% | 2664 |
|
|
2024
Q3 | $25K | Hold |
2,444
| – | – | ﹤0.01% | 2547 |
|
|
2024
Q2 | $36.3K | Hold |
2,444
| – | – | ﹤0.01% | 2314 |
|
|
2024
Q1 | $33.3K | Hold |
2,444
| – | – | ﹤0.01% | 2344 |
|
|
2023
Q4 | $26.8K | Hold |
2,444
| – | – | ﹤0.01% | 2453 |
|
|
2023
Q3 | $26.8K | Buy |
2,444
+839
| +52% | +$10.7K | ﹤0.01% | 2414 |
|
|
2023
Q2 | $21.3K | Hold |
1,605
| – | – | ﹤0.01% | 2532 |
|
|
2023
Q1 | $21.8K | Hold |
1,605
| – | – | ﹤0.01% | 2431 |
|
|
2022
Q4 | $33.8K | Hold |
1,605
| – | – | ﹤0.01% | 2295 |
|
|
2022
Q3 | $30K | Hold |
1,605
| – | – | ﹤0.01% | 2304 |
|
|
2022
Q2 | $33K | Hold |
1,605
| – | – | ﹤0.01% | 2259 |
|
|
2022
Q1 | $52K | Hold |
1,605
| – | – | ﹤0.01% | 2045 |
|
|
2021
Q4 | $75K | Hold |
1,605
| – | – | ﹤0.01% | 1860 |
|
|
2021
Q3 | $43K | Hold |
1,605
| – | – | ﹤0.01% | 2259 |
|
|
2021
Q2 | $41K | Hold |
1,605
| – | – | ﹤0.01% | 2315 |
|
|
2021
Q1 | $55K | Buy |
1,605
+694
| +76% | +$25.1K | ﹤0.01% | 2031 |
|
|
2020
Q4 | $31K | Hold |
911
| – | – | ﹤0.01% | 2254 |
|
|
2020
Q3 | $22K | Buy |
+911
| New | +$24.5K | ﹤0.01% | 2320 |
|
Other funds holding ITOS
Ameritas Investment Partners's ITOS Position: Q3 2025 in Review
Ameritas Investment Partners sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 2,444 shares — an estimated $24.4K sold.
Ameritas Investment Partners first reported a position in ITOS in Q3 2020 and held it in 20 quarters. The position peaked at $75K in Q4 2021. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.
- Ameritas Investment Partners reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
- Ameritas Investment Partners sold 2,444 iTeos Therapeutics shares in Q3 2025, an estimated $24.4K.
- Ameritas Investment Partners first reported a position in iTeos Therapeutics in Q3 2020 and held it in 20 quarters.
- Ameritas Investment Partners's iTeos Therapeutics position peaked at $75K in Q4 2021.
- 1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.
Based on Ameritas Investment Partners's 13F filing for Q3 2025, filed 10 Nov 2025.